Nexus AG 0FGL.L Stock
Nexus AG Price Chart
Nexus AG 0FGL.L Financial and Trading Overview
Nexus AG stock price | 56.81 EUR |
Previous Close | 58.4 EUR |
Open | 0 EUR |
Bid | 0 EUR x 0 |
Ask | 0 EUR x 0 |
Day's Range | 0 - 0 EUR |
52 Week Range | 0 - 64.4 EUR |
Volume | 7.6K EUR |
Avg. Volume | 2.76K EUR |
Market Cap | 9.04M EUR |
Beta (5Y Monthly) | 0.780459 |
PE Ratio (TTM) | 0.51696426 |
EPS (TTM) | 1.12 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0FGL.L Valuation Measures
Enterprise Value | 898.76M EUR |
Trailing P/E | 0.51696426 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.041578256 |
Price/Book (mrq) | 4.1651683 |
Enterprise Value/Revenue | 4.135 |
Enterprise Value/EBITDA | 26.688 |
Trading Information
Nexus AG Stock Price History
Beta (5Y Monthly) | 0.780459 |
52-Week Change | 20.62% |
S&P500 52-Week Change | 20.43% |
52 Week High | 64.4 EUR |
52 Week Low | 0 EUR |
50-Day Moving Average | 53.83 EUR |
200-Day Moving Average | 53.22 EUR |
0FGL.L Share Statistics
Avg. Volume (3 month) | 2.76K EUR |
Avg. Daily Volume (10-Days) | 2.16K EUR |
Shares Outstanding | 15.73M |
Float | 15.78M |
Short Ratio | N/A |
% Held by Insiders | 12.39% |
% Held by Institutions | 61.83% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.21 |
Trailing Annual Dividend Yield | 0.35% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 9.58% |
Operating Margin (ttm) | 12.16% |
Gross Margin | 28.28% |
EBITDA Margin | 15.49% |
Management Effectiveness
Return on Assets (ttm) | 5.14% |
Return on Equity (ttm) | 10.84% |
Income Statement
Revenue (ttm) | 217.38M EUR |
Revenue Per Share (ttm) | 13.32 EUR |
Quarterly Revenue Growth (yoy) | 11.70% |
Gross Profit (ttm) | 58.61M EUR |
EBITDA | 33.68M EUR |
Net Income Avi to Common (ttm) | 20.84M EUR |
Diluted EPS (ttm) | 1.12 |
Quarterly Earnings Growth (yoy) | 35.79% |
Balance Sheet
Total Cash (mrq) | 130.85M EUR |
Total Cash Per Share (mrq) | 7.59 EUR |
Total Debt (mrq) | 19.41M EUR |
Total Debt/Equity (mrq) | 7.98 EUR |
Current Ratio (mrq) | 2.139 |
Book Value Per Share (mrq) | 13.901 |
Cash Flow Statement
Operating Cash Flow (ttm) | 28.35M EUR |
Levered Free Cash Flow (ttm) | 20.05M EUR |
Profile of Nexus AG
Country | United Kingdom |
State | N/A |
City | Donaueschingen |
Address | Irmastrasse 1 |
ZIP | 78166 |
Phone | 49 771 22960 0 |
Website | https://www.nexus-ag.de |
Industry | |
Sector(s) | |
Full Time Employees | 1700 |
Nexus AG develops and sells software and hardware solutions, and provides information technology (IT) services, primarily for customers in the health care system worldwide. It operates through two segments, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY, dc-Pathos and dc-LabMan for pathological and cytological devices, print management for cassette, and slide printers; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HIS, for somatic hospitals in Switzerland; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; and NEXUS/PAT, an administration system for hospitals. In addition, the company offers SINAPSI, osoTEC, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, NEXUS/ESKULAP, One ICT, PathoPro, IBS, Heimsoft, Wintime 2000, and GEPADO Xpro. NEXUS AG is headquartered in Donaueschingen, Germany.
Q&A For Nexus AG Stock
What is a current 0FGL.L stock price?
Nexus AG 0FGL.L stock price today per share is 56.81 EUR.
How to purchase Nexus AG stock?
You can buy 0FGL.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nexus AG?
The stock symbol or ticker of Nexus AG is 0FGL.L.
How many shares does Nexus AG have in circulation?
The max supply of Nexus AG shares is 156.1K.
What is Nexus AG Price to Earnings Ratio (PE Ratio)?
Nexus AG PE Ratio is 0.50721890 now.
What was Nexus AG earnings per share over the trailing 12 months (TTM)?
Nexus AG EPS is 1.12 EUR over the trailing 12 months.